These findings imply that even in atrophic DFSP, detection of the COL1A1-PDGFB fusion gene is a powerful tool for molecular diagnosis to differentiate other benign/malignant neoplasms. This evidence concerns the gene PDGFB and dermatofibrosarcoma protuberans.